# FDA 483 - Nippon Fine Chemical Co., Ltd. - June 11, 2019

Source: https://www.globalkeysolutions.net/records/483/nippon-fine-chemical-co-ltd/de5dea24-ded0-4b35-acf8-f3f462ad6df9

> FDA 483 for Nippon Fine Chemical Co., Ltd. on June 11, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nippon Fine Chemical Co., Ltd.
- Inspection Date: 2019-06-11
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-11-14](https://www.globalkeysolutions.net/records/483/nippon-fine-chemical-co-ltd/43ec991a-8c6d-44a6-b32b-4079a51825f5)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/nippon-fine-chemical-co-ltd/ca521d5b-285e-4590-9a80-6b4236ef824b)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/nippon-fine-chemical-co-ltd/c51d164b-18e2-4818-aa62-f84a1e19a0b2)

## Related Officers

- [Tonia F. Bernard](https://www.globalkeysolutions.net/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.globalkeysolutions.net/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd